Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma

GC33 is a humanized mAb against human glypican-3 (GPC3). In the first-in-human study carried out in the USA, GC33 was well tolerated and showed preliminary antitumor activity in patients with advanced hepatocellular carcinoma. This study aimed to assess the safety, tolerability, and pharmacokinetic...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Sci
Main Authors: Ikeda, Masafumi, Ohkawa, Shinichi, Okusaka, Takuji, Mitsunaga, Shuichi, Kobayashi, Satoshi, Morizane, Chigusa, Suzuki, Ikue, Yamamoto, Shunsuke, Furuse, Junji
格式: Artigo
語言:Inglês
出版: Blackwell Publishing Ltd 2014
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317809/
https://ncbi.nlm.nih.gov/pubmed/24521523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12368
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍